Amedeo Smart

Free Medical Literature Service

 

Amedeo

Nuclear Medicine
  Free Subscription

Articles published in
Nuklearmedizin
    August 2026
  1. OLDAN JD, Schroeder JA, Jeyasingam M, Solnes LB, et al
    Quantitative Reconstructions for Renal Sestamibi SPECT/CT: A Modeled Comparison of 360-Degree Versus 180-Degree Acquisitions.
    Nuklearmedizin. 2026 Aug 11. doi: 10.1055/a-2914-2268.
    >> Share

    July 2026
  2. BUCHERT R, Albert NL, Barthel H, Boecker H, et al
    German Society of Nuclear Medicine procedure guideline for dopamine transporter SPECT using [123I]ioflupane (02/2026).
    Nuklearmedizin. 2026 Jul 28. doi: 10.1055/a-2883-7728.
    >> Share

  3. BALTACIOGLU MH
    Detection of Brain Metastasis in Occult Medullary Thyroid Carcinoma Using (6)(8)Ga-DOTATATE PET/CT: A Case Report.
    Nuklearmedizin. 2026 Jul 27. doi: 10.1055/a-2892-1094.
    >> Share

  4. BOSBACH WA, Manser V, Bregenzer CM, Gozlugol N, et al
    FDG-PET/CT in children with malignant diseases - comparison of a long axial field of view scanner with a standard scanner.
    Nuklearmedizin. 2026 Jul 23. doi: 10.1055/a-2912-4818.
    >> Share

    June 2026
  5. BUDDENKOTTE T, Apostolova II, Opfer R, Klutmann S, et al
    On the utility of ChatGPT in conducting a literature review on deep learning for dopamine transporter SPECT with [(1)(2)(3)I]ioflupane.
    Nuklearmedizin. 2026 Jun 24. doi: 10.1055/a-2890-8325.
    >> Share

  6. LIAO T, Fu G, Long Y, Li L, et al
    McCune-Albright Syndrome with Extensive Fibrous Dysplasia Evaluated by 18F-FDG PET/CT and Whole-body Bone Scintigraphy: A Case Report.
    Nuklearmedizin. 2026 Jun 24. doi: 10.1055/a-2843-4797.
    >> Share

  7. BALTACIOGLU MH
    False-Positive Rib Lesion on Bone Scintigraphy and 68Ga-PSMA PET/CT: Fibrous Dysplasia Mimicking Metastasis.
    Nuklearmedizin. 2026 Jun 24. doi: 10.1055/a-2843-4897.
    >> Share

  8. TATOGLU MT, Uslu H
    [68Ga]Ga-FAPI-04 PET/CT Delineates Peritoneal Carcinomatosis in Invasive Lobular Breast Cancer with Limited FDG Avidity.
    Nuklearmedizin. 2026 Jun 11. doi: 10.1055/a-2883-7848.
    >> Share

  9. BUCHERT R, Meyer PT, Albert NL, Barthel H, et al
    German Society of Nuclear Medicine procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals (09/2025).
    Nuklearmedizin. 2026 Jun 2. doi: 10.1055/a-2821-9573.
    >> Share

  10. BARTHEL H, Brendel M, Albert N, Boecker H, et al
    Updated Procedure Guideline of the German Society of Nuclear Medicine for Amyloid Brain PET Imaging 3.0.
    Nuklearmedizin. 2026;65:223-235.
    >> Share

  11. TATOGLU MT, Okten IN, Ibisoglu E, Soylemez Akkurt T, et al
    Baseline FDG PET/CT-Defined Axillary Burden Predicts Axillary Pathologic Complete Response After Neoadjuvant Therapy in Breast Cancer.
    Nuklearmedizin. 2026;65:207-216.
    >> Share

  12. SIEGMUND SC, Serfling SE, Higuchi T, Buck A, et al
    Emerging Theranostic Targets in Squamous Cell Carcinoma of the Head and Neck.
    Nuklearmedizin. 2026;65:217-222.
    >> Share

    May 2026
  13. KARASKIWIECZ E, Syka A, Mottaghy FM, Lutje S, et al
    Late post-treatment 131I SPECT/CT reveals additional lymph node metastasis of papillary thyroid carcinoma.
    Nuklearmedizin. 2026 May 6. doi: 10.1055/a-2852-9891.
    >> Share

    April 2026
  14. LEONTEV A, Lokhova A, Khalimon A, Khodzhibekova M, et al
    Impact assessment of [18F]FDG PET/CT in predicting EGFR gene mutation status in patients with lung adenocarcinoma using recovery coefficient-based correction of semi-quantitative and volume-based PET metrics.
    Nuklearmedizin. 2026 Apr 13. doi: 10.1055/a-2777-2278.
    >> Share

  15. ROGASCH JMM, Amthauer H, Kluge R, Bares R, et al
    DGN procedural guideline for bone scintigraphy with SPECT and SPECT/CT in children and adolescents.
    Nuklearmedizin. 2026 Apr 10. doi: 10.1055/a-2784-7659.
    >> Share

  16. SUN TT, Zhu LB, Jiang L, Liu ET, et al
    [18F]FDG PET/CT diagnosis and follow-up of arterial intimal sarcoma of the left atrium.
    Nuklearmedizin. 2026;65:93-96.
    >> Share

  17. APOSTOLOVA II, Buddenkotte T, Jedid L, Klutmann S, et al
    Difficult-to-interpret dopamine transporter SPECT with [123I]ioflupane in the diagnosis of parkinsonism.
    Nuklearmedizin. 2026;65:83-92.
    >> Share

  18. LINDNER O, Goetz C, Bengel FM, Linke A, et al
    Nuclear cardiology - Current status of the clinical application.
    Nuklearmedizin. 2026;65:52-59.
    >> Share

    February 2026
  19. FREESMEYER M, Kuhnel C, Voigt E, Schmidt TN, et al
    Radioiodine Therapy Unit as a "No-Care" Ward - A First Experience Report.
    Nuklearmedizin. 2026;65:22-29.
    >> Share

    December 2025
  20. MONSEF A, Saboktakin F, Sadeghi F, Elhaie M, et al
    Experimental approach for optimizing dose regimen of 68Ga-DOTATATE PET/CT for neuroendocrine tumor (NET) imaging in current high sensitivity scanners: Phantom and Patient Study.
    Nuklearmedizin. 2025;64:341-351.
    >> Share

  21. KRATZER W, Steinkellner S, Skotnik D, Peters L, et al
    Diagnosis of hepatic alveolar echinococcosis:18F-FDG-PET activity compared to the Echinococcus multilocularis Ulm Ultrasound Classification.
    Nuklearmedizin. 2025 Dec 1. doi: 10.1055/a-2744-4139.
    >> Share

    November 2025
  22. LINDNER O, Gutberlet M, Burchert W, Derlin T, et al
    Myocardial Perfusion SPECT 2024 in Germany: Results of the 10th Survey.
    Nuklearmedizin. 2025 Nov 24. doi: 10.1055/a-2738-2589.
    >> Share

    October 2025
  23. VOLTIN CA, Kottlors J, Borchmann P, Godel P, et al
    Performance of a large language model in lymphoma stage assignment based on written PET/CT reports.
    Nuklearmedizin. 2025 Oct 14. doi: 10.1055/a-2707-4584.
    >> Share

  24. KALANTARI F, Rendl G, Hecht S, Pirich C, et al
    Atypical local laryngeal cancer recurrence mimicking thyroid uptake on 18F-FDG PET/CT.
    Nuklearmedizin. 2025;64:316-317.
    >> Share

  25. MANDIC A, Kraljevic I, Skoric Polovina T, Zibar Tomsic K, et al
    Diagnostic Performance of 99 mTc-Sestamibi SPECT/CT and 18F-Choline PET/CT in Locating Hyperfunctioning Parathyroid Glands in Patients with Primary Hyperparathyroidism.
    Nuklearmedizin. 2025;64:308-312.
    >> Share

  26. AMBULKAR KS, Shah R, Lila A, Sharma A, et al
    Outcomes of 68Ga-NODAGA-Exendin-4 PET/CT Guided Surgical Management of Insulinomas in MEN1: A Preliminary Study.
    Nuklearmedizin. 2025;64:301-307.
    >> Share

  27. MIKSCH J, Yousefzadeh-Nowshahr E, Hardiansyah D, Glatting G, et al
    First clinical application of silicon-based [(1)(8)F]siPSMA-14 in prostate cancer patients: A proof-of-concept study.
    Nuklearmedizin. 2025;64:285-293.
    >> Share

    September 2025
  28. CHIKASUE T, Kurata S, Edamitsu S, Koganemaru M, et al
    Central Conducting Lymphatic Abnormalities in Noonan Syndrome Identified Using SPECT/CT Lymphoscintigraphy.
    Nuklearmedizin. 2025 Sep 30. doi: 10.1055/a-2695-8007.
    >> Share

    August 2025
  29. OKUDAN B, Atalay M, Hakkoymaz ZR, Seven B, et al
    Diagnostic value of presurgical 68Ga-PSMA-11 PET/CT in prostate cancer patients with different ISUP grade groups.
    Nuklearmedizin. 2025 Aug 22. doi: 10.1055/a-2665-8087.
    >> Share

  30. JOZANOVIC V, Lukic D, Brataljenovic M, Huic D, et al
    Diagnostic challenge in parathyroid imaging: incidental schwannoma mimicking primary hyperparathyroidism on 18F-fluorocholine PET/CT.
    Nuklearmedizin. 2025 Aug 22. doi: 10.1055/a-2655-5291.
    >> Share

  31. TATOGLU MT, Alan Selcuk N, Erincik K
    Benign bone lesions mimicking metastasis on 68Ga-FAPI PET/CT.
    Nuklearmedizin. 2025;64:277-280.
    >> Share

  32. GAMMEL MCM, Hansen K, Weber W, Rauscher I, et al
    From Metastases to Splenosis: Resolving SSR PET Pitfalls with Tc-99m-Labeled Denatured Red Blood Cell Scintigraphy.
    Nuklearmedizin. 2025;64:272-273.
    >> Share

    June 2025
  33. LIU S, Pan Q, Xu H, Luo Y, et al
    Activation of fibroblast in intestinal Behcet's disease shown by 68Ga-FAPI-04 PET/CT.
    Nuklearmedizin. 2025;64:231-233.
    >> Share

  34. YANG H, Zhang Y, Guan Z, Li C, et al
    The diagnostic performance of an [18F]FDG PET/CT algorithm for preoperative evaluation of extrahepatic cholangiocarcinoma: a retrospective study.
    Nuklearmedizin. 2025;64:205-214.
    >> Share

  35. DROPMANN JA, Kleespies A, Fuerst H, Kremer M, et al
    Importance of oxyphil cells for 99mTc-sestamibi uptake in primary hyperparathyroidism: a retrospective observational study.
    Nuklearmedizin. 2025;64:215-224.
    >> Share

    May 2025
  36. WENDLER T, Rogasch JMM, Bastian MB, Burchert W, et al
    Correction: Digitalization of Nuclear Medicine in Germany - Status Quo 2024.
    Nuklearmedizin. 2025 May 20. doi: 10.1055/a-2604-5823.
    >> Share

  37. BAEHR M, Dietrich I, Liepe K
    [99mTc]Tc-PSMA SPECT/CT is a promising tool in the staging of renal cell carcinoma.
    Nuklearmedizin. 2025 May 12. doi: 10.1055/a-2578-7222.
    >> Share

    April 2025
  38. BUCHERT R, Drzezga A, Schreckenberger M, Langen KJ, et al
    The Status of Neuroimaging with SPECT and PET in Germany: Results from the 1st Survey on Nuclear Neuroimaging in Germany in 2023.
    Nuklearmedizin. 2025 Apr 15. doi: 10.1055/a-2566-1487.
    >> Share

  39. LUNA R, Laheru DA, Shin EJ, Lossos C, et al
    Pancreatic Neuroendocrine Tumor incidentally found on 68Ga-PSMA PET/CT.
    Nuklearmedizin. 2025;64:177-179.
    >> Share

  40. WENDLER T, Rogasch JMM, Bastian MB, Burchert W, et al
    Digitalization of Nuclear Medicine in Germany - Status Quo 2024.
    Nuklearmedizin. 2025;64:156-162.
    >> Share

  41. ORBOM A, Evans-Axelsson S, Jansson B, Vilhelmsson Timmermand O, et al
    Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse model.
    Nuklearmedizin. 2025;64:163-169.
    >> Share

  42. EBRAHIMIFARD A, Rajabi H, Geramifar P, Luster M, et al
    The impact of the xSPECT reconstruction algorithms on the recovery coefficients value for small tumors: a phantom study with 177Lu.
    Nuklearmedizin. 2025;64:132-140.
    >> Share

  43. VOGT JK, Vogt WK, Heinzel A, Mottaghy FM, et al
    Comparison of 2D and 3D lung lobe quantification with Ventilation/Perfusion Ratio.
    Nuklearmedizin. 2025;64:142-149.
    >> Share

    March 2025
  44. BAUDE JK, Mottaghy FM, Derlin T, Fischer A, et al
    PSMA - Targeted Clinical Molecular Imaging of Atherosclerosis: Correlation with Cardiovascular Risk Factors.
    Nuklearmedizin. 2025;64:13-21.
    >> Share

    January 2025
  45. VURAL TOPUZ O, Bagbudar S, Aksu A, Soylemez Akkurt T, et al
    Radiomic signatures derived from baseline 18F FDG PET/CT imaging can predict tumor-infiltrating lymphocyte values in patients with primary breast cancer.
    Nuklearmedizin. 2025 Jan 28. doi: 10.1055/a-2512-8212.
    >> Share

    December 2024
  46. CEGLA P, Currie G, Wroblewska JP, Kazmierska J, et al
    [18F]FDG PET/CT Imaging and Hematological Parameters Can Help Predict HPV Status in Head and Neck Cancer.
    Nuklearmedizin. 2024 Dec 4. doi: 10.1055/a-2365-7808.
    >> Share

  47. GRUNERT M, Schenke SA, Konrad A, Schutze C, et al
    Thyroid scintigraphy: establishing a clinically useful normal range for 99mTc pertechnetate uptake.
    Nuklearmedizin. 2024;63:337-346.
    >> Share

    November 2024
  48. RUGGIERO C, Maracaja D, Rowe SP
    Langerhans Cell Histiocytosis-Associated Vertebra Plana on FDG PET.
    Nuklearmedizin. 2024 Nov 27. doi: 10.1055/a-2438-7469.
    >> Share

  49. ZHAO G, Huang Z
    A Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor on 18F-FDG PET/CT.
    Nuklearmedizin. 2024 Nov 20. doi: 10.1055/a-2383-2527.
    >> Share

  50. SCHULZ L, Funk GC, Kirchbacher K, Egger E, et al
    Comparison of whole-body 18F-FDG-PET/CT with 18F-FDG-PET/CT limited to skull base to upper abdomen for primary staging of lung cancer - a retrospective explorative analysis.
    Nuklearmedizin. 2024 Nov 11. doi: 10.1055/a-2438-7278.
    >> Share

    October 2024
  51. VOLTIN CA, Spreckelmeyer S, Essler M, Holzgreve A, et al
    Toward the future of nuclear medicine: How young professionals are getting involved and what plans they have.
    Nuklearmedizin. 2024;63:284-286.
    >> Share

  52. VOGEL J, Haghghi S, Herkula C, Petersen M, et al
    Interobserver Agreement of visual and semi-quantitative methods in 99mTc-Methoxy-Isobuty-Isonitrile (MIBI) imaging for risk stratification of hypofunctional thyroid nodules.
    Nuklearmedizin. 2024;63:294-299.
    >> Share

  53. ZEIDLER R, Tiepolt S, Hesse S, Sabri O, et al
    Superimposing kidneys in [99mTc]MAG-3 and [99mTc]DMSA-scintigraphy in a tricky case of an extensive, displacing growing retroperitoneal liposarcoma.
    Nuklearmedizin. 2024;63:306-307.
    >> Share

    September 2024
  54. JAFARI E, Manafi-Farid R, Ahmadzadehfar H, Salek F, et al
    Prognostic Significance of Baseline Clinical and [68Ga]Ga-PSMA PET Derived Parameters on Biochemical Response, Overall Survival, and PSA Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Undergoing [177Lu]Lu
    Nuklearmedizin. 2024 Sep 3. doi: 10.1055/a-2365-8113.
    >> Share

    August 2024
  55. RAHBAR NIKOUKAR L, Seifert R, Ventura D, Schindler P, et al
    Prognostic value of pretherapeutic 68Ga-PSMA-11-PET based imaging parameters in mCRPC patients treated with PSMA radioligands.
    Nuklearmedizin. 2024 Aug 29. doi: 10.1055/a-2383-2468.
    >> Share

  56. VOGT JK, Vogt WK, Heinzel A, Mottaghy FM, et al
    Computational Decision Support for PE Diagnosis based on Ventilation Perfusion Ratio.
    Nuklearmedizin. 2024;63:259-266.
    >> Share

    July 2024
  57. LANDAU F, Hermann S, Schelhaas S, Schafers M, et al
    18F-labelled gentiobiose as potential PET-radiotracer for specific bacterial imaging: precursor synthesis, radiolabelling and in vitro evaluation.
    Nuklearmedizin. 2024 Jul 31. doi: 10.1055/a-2365-8054.
    >> Share

  58. BREDENSTEINER L, Ventura D, Rassek P, Schafers M, et al
    Determination of the optimal imaging protocol for [18F]PSMA-PET-CT for the detection of bone metastases in prostate cancer patients.
    Nuklearmedizin. 2024 Jul 12. doi: 10.1055/a-2344-6825.
    >> Share

    May 2024
  59. SCHMIDT M, Hohberg M, Felcht M, Kuhn T, et al
    [Nuclear medicine procedure guideline for sentinel lymph node localization].
    Nuklearmedizin. 2024 May 24. doi: 10.1055/a-2319-8306.
    >> Share

  60. HEIDEMANNS S, Trautmann S, Weidt D, Hellwig D, et al
    Update of the competence-based catalog of learning objectives in nuclear medicine for the study of human medicine in Germany.
    Nuklearmedizin. 2024 May 22. doi: 10.1055/a-2319-7549.
    >> Share

    April 2024
  61. WIELENBERG CF, Fostitsch JC, Volz C, Marks R, et al
    FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL).
    Nuklearmedizin. 2024 Apr 9. doi: 10.1055/a-2283-8417.
    >> Share

  62. BOCK F, Frerker B, Schubert L, Rennau H, et al
    Impact of 68Ga-PSMA PET/CT on radiation treatment planning of prostate cancer patients.
    Nuklearmedizin. 2024 Apr 5. doi: 10.1055/a-2284-0593.
    >> Share

  63. SAEED S, Dimopoulos I, Begum N, Kroger JR, et al
    [Not Available].
    Nuklearmedizin. 2024;63:78-80.
    >> Share

  64. WERNER R, Haug A, Buske C, Heidegger S, et al
    CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges.
    Nuklearmedizin. 2024;63:57-61.
    >> Share

    March 2024
  65. GACULA SIG, Kunte SC, Unterrainer LM, Rubenthaler J, et al
    Correction: Divergent growth on [18F]FDG PET/CT in a case of co-existing pulmonary metastatic leiomyosarcoma and papillary thyroid carcinoma.
    Nuklearmedizin. 2024 Mar 25. doi: 10.1055/a-2286-9571.
    >> Share

  66. USLU H, Sahin D, Tatoglu MT, Ibisoglu E, et al
    Growing Teratoma Syndrome Revealed By F-18 FDG PET/CT.
    Nuklearmedizin. 2024 Mar 14. doi: 10.1055/a-2273-2350.
    >> Share

  67. GACULA SIG, Kunte SC, Unterrainer LM, Rubenthaler J, et al
    Divergent growth on [18F]FDG PET/CT in a case of co-existing pulmonary metastatic leiomyosarcoma and papillary thyroid carcinoma.
    Nuklearmedizin. 2024 Mar 11. doi: 10.1055/a-2273-2447.
    >> Share

  68. LIU Y, Tang W, Huang Z
    Correction: 99mTc-MDP Bone Scan and 18F-FDG PET/CT Imaging of Primary Hepatic Osteosarcoma.
    Nuklearmedizin. 2024 Mar 4. doi: 10.1055/a-2275-1035.
    >> Share

    February 2024
  69. CHEN M, Liu Y
    Correction: 18F-FDG PET/CT images of adult pulmonary blastoma: a case report.
    Nuklearmedizin. 2024 Feb 20. doi: 10.1055/a-2265-4049.
    >> Share

  70. AYDAR S, Knobl H, Burchert W, Lindner O, et al
    Diagnostic accuracy of artificial intelligence-enabled vectorcardiography versus myocardial perfusion SPECT in patients with suspected or known coronary heart disease.
    Nuklearmedizin. 2024 Feb 20. doi: 10.1055/a-2263-2322.
    >> Share

  71. CHEN M, Liu Y
    18F-FDG PET/CT images of adult pulmonary blastoma: a case report.
    Nuklearmedizin. 2024 Feb 7. doi: 10.1055/a-2237-8775.
    >> Share

  72. UMUTLU L, Nensa F, Demircioglu A, Antoch G, et al
    Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients with Primary Cervical Cancer.
    Nuklearmedizin. 2024;63:34-42.
    >> Share

  73. FISCHER M, Schneider-Eicke J
    Nonosseous bone seeking tracer focal uptake in the conventional scintigraphy.
    Nuklearmedizin. 2024;63:45-47.
    >> Share

  74. DIETLEIN M, Grunwald F, Schmidt M, Kreissl MC, et al
    [Guideline for Radioiodine Therapy for Benign Thyroid Diseases (6/2022 - AWMF No. 031-003)].
    Nuklearmedizin. 2024;63:8-20.
    >> Share

    January 2024
  75. FREUDENBERG R, Kastner D, Kotzerke J, Brogsitter C, et al
    [Evaluation of risk analysis in treatment with unsealed radioactive substances in nuclear medicine].
    Nuklearmedizin. 2024 Jan 23. doi: 10.1055/a-2237-8639.
    >> Share

  76. MAMAN A
    Incidental Papillary Thyroid Carcinoma Detected by Ga-68 DOTATATE PET/CT: A Rare Case Study and Clinical Considerations.
    Nuklearmedizin. 2024 Jan 23. doi: 10.1055/a-2238-4186.
    >> Share

  77. NOURBAKHSH S, Salehi Y, Farzanehfar S, Ghaletaki R, et al
    FAPI PET/CT provides higher uptake and better target to back ground in recurrent and metastatic tumors of patients with Iodine refractory papillary thyroid cancer compared with FDG PET CT.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2185-7746.
    >> Share

  78. ARSLANTAS E, Aycicek A, Esen Akkas B, Tahtakesen Gucer TN, et al
    The Role of FDG- PET/CT in Detecting Bone Marrow Involvement in Childhood Solid Tumors.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2224-9441.
    >> Share

  79. VURAL TOPUZ O, Bagbudar S
    Cervical Cancer Metastasis to the Stomach Masquerading as Primary Gastric Cancer: A Case Report of a Rare Metastasis Detected via 18F-FDG PET/CT.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2224-9673.
    >> Share

  80. SANTO G, Di Santo G, Zelger B, Virgolini I, et al
    Incidental Finding of a Pancreatic Adenocarcinoma on [68Ga]Ga-PSMA-11 PET/CT in a mCRPC patient under [177Lu]Lu-PSMA-617 Radioligand Therapy.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2221-3220.
    >> Share

    December 2023
  81. SERFLING SE, Buck A, Rowe SP, Higuchi T, et al
    Red Bull PET/CT.
    Nuklearmedizin. 2023 Dec 22. doi: 10.1055/a-2195-0138.
    >> Share

  82. ROGASCH JMM, Shi K, Kersting D, Seifert R, et al
    Methodological evaluation of original articles on radiomics and machine learning for outcome prediction based on positron emission tomography (PET).
    Nuklearmedizin. 2023;62:361-369.
    >> Share

  83. WENDLER T, Kreissl MC, Schemmer B, Rogasch JMM, et al
    Artificial Intelligence-powered automatic volume calculation in medical images - available tools, performance and challenges for nuclear medicine.
    Nuklearmedizin. 2023;62:343-353.
    >> Share

  84. HELLWIG D, Hellwig NC, Boehner S, Fuchs T, et al
    Artificial Intelligence and Deep Learning for Advancing PET Image Reconstruction: State-of-the-Art and Future Directions.
    Nuklearmedizin. 2023;62:334-342.
    >> Share

  85. MIEDERER I, Rogasch JMM, Wendler T
    AI in Nuclear Medicine - a review of the current situation.
    Nuklearmedizin. 2023;62:332-333.
    >> Share

    November 2023
  86. LOHMANN P, Bundschuh RA, Miederer I, Mottaghy FM, et al
    Clinical Applications of Radiomics in Nuclear Medicine.
    Nuklearmedizin. 2023 Nov 7. doi: 10.1055/a-2191-3271.
    >> Share

    October 2023
  87. FUCHS T, Kaiser L, Muller D, Papp L, et al
    Enhancing Interoperability and Harmonisation of Nuclear Medicine Image Data and Associated Clinical Data.
    Nuklearmedizin. 2023 Oct 31. doi: 10.1055/a-2187-5701.
    >> Share

  88. RASSEK P, Bobe S, Kies P, Roll W, et al
    The value of core needle biopsy in the diagnostic workup of a [18F]FDG-PET positive thyroid metastasis from colorectal cancer.
    Nuklearmedizin. 2023 Oct 23. doi: 10.1055/a-2178-6908.
    >> Share

  89. BROSCH-LENZ JF, Delker A, Schmidt F, Tran-Gia J, et al
    On the Use of Artificial Intelligence for Dosimetry of Radiopharmaceutical Therapies.
    Nuklearmedizin. 2023 Oct 12. doi: 10.1055/a-2179-6872.
    >> Share

  90. MOON H, Ku EJ, Kim C
    Ectopic Thyroid Tissue in the Uterus Identified by Iodine-131 SPECT/CT.
    Nuklearmedizin. 2023;62:294-295.
    >> Share

  91. KUSTNER T, Hepp T, Seith F
    Multiparametric Oncologic Hybrid Imaging: Machine Learning Challenges and Opportunities.
    Nuklearmedizin. 2023;62:306-313.
    >> Share

    September 2023
  92. DEININGER K, Raacke JN, Yousefzadeh-Nowshahr E, Kropf-Sanchen C, et al
    Combined morphologic-metabolic biomarkers from [18F]FDG-PET/CT stratify prognostic groups in low-risk NSCLC.
    Nuklearmedizin. 2023 Sep 11. doi: 10.1055/a-2150-4130.
    >> Share

  93. MIEDERER I, Rogasch JMM, Fischer R, Fuchs T, et al
    The Medical Informatics Initiative and the Network University Medicine - Perspectives for Nuclear Medicine.
    Nuklearmedizin. 2023 Sep 8. doi: 10.1055/a-2067-7642.
    >> Share

    August 2023
  94. FROHLICH M, Schmalzing M, Buck A, Bley TA, et al
    PET-Derived Increased Inflammation in Large Vessels is linked to Relapse-Free Survival in Patients with Giant Cell Arteritis.
    Nuklearmedizin. 2023;62:229-234.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016